UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Rivaroxaban in Peripheral Artery Disease after Revascularization

The New England journal of medicine, 2020-05, Vol.382 (21), p.1994-2004

2020

Link zum Volltext

Verfügbarkeit prüfen

Fondaparinux Sodium: Recent Advances in the Management of Thrombosis

Journal of Cardiovascular Pharmacology and Therapeutics, 2023-01, Vol.28, p.10742484221145010

Bauersachs, Rupert M.

2023

Link zum Volltext

Verfügbarkeit prüfen

Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs

The New England journal of medicine, 2010-09, Vol.363 (13), p.1222-1232

2010

Link zum Volltext

Verfügbarkeit prüfen

Superficial Vein Thrombosis

Deutsche medizinische Wochenschrift (1946), 2021-10, Vol.146 (19), p.1237

Bauersachs, Rupert M

2021

Link zum Volltext

Verfügbarkeit prüfen

Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD

Vascular medicine (London, England), 2022-08, Vol.27 (4), p.343-349

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women

Thrombosis and haemostasis, 2007-12, Vol.98 (6), p.1237

2007

Link zum Volltext

Verfügbarkeit prüfen

Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD

Vascular medicine (London, England), 2024-04, Vol.29 (2), p.143-152

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical presentation of deep vein thrombosis and pulmonary embolism

Best practice & research. Clinical haematology, 2012-09, Vol.25 (3), p.243-251

Bauersachs, Rupert M., MD

2012

Link zum Volltext

Verfügbarkeit prüfen

Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD

Journal of the American Heart Association, 2022-06, Vol.11 (12), p.e024655-e024655

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of venous thromboembolism during pregnancy

Thrombosis research, 2009, Vol.123, p.S45-S50

Bauersachs, Rupert M

2009

Link zum Volltext

Verfügbarkeit prüfen

Use of anticoagulants in elderly patients

Thrombosis research, 2012-02, Vol.129 (2), p.107-115

Bauersachs, Rupert M

2012

Link zum Volltext

Verfügbarkeit prüfen

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

European heart journal, 2020-01, Vol.41 (4), p.509-518

2020

Link zum Volltext

Verfügbarkeit prüfen

LMWH in cancer patients with renal impairment – better than warfarin?

Thrombosis research, 2016-04, Vol.140, p.S160-S164

Bauersachs, Rupert M

2016

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

The New England journal of medicine, 2020-11, Vol.383 (21), p.2090-2091

2020

Link zum Volltext

Verfügbarkeit prüfen

Managing venous thromboembolism with novel oral anticoagulants in the elderly and other high-risk patient groups

European journal of internal medicine, 2014-09, Vol.25 (7), p.600-606

Bauersachs, Rupert M

2014

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the management of cancer and thrombosis – Special aspects in women

Thrombosis research, 2015-02, Vol.135, p.S16-S22

Bauersachs, Rupert M

2015

Link zum Volltext

Verfügbarkeit prüfen

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Journal of the American College of Cardiology, 2021-07, Vol.78 (4), p.317-326

2021

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2023-12, Vol.148 (24), p.1919

2023

Link zum Volltext

Verfügbarkeit prüfen

Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2024-02, Vol.149 (8), p.635

2024

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial

Journal of the American College of Cardiology, 2021-08, Vol.78 (7), p.757-759

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (14), p.1104-1116

2021

Link zum Volltext

Verfügbarkeit prüfen

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis

Thrombosis and haemostasis, 2016-10, Vol.116 (4), p.733

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Circulation (New York, N.Y.), 2021-12, Vol.144 (23), p.1831-1841

2021

Link zum Volltext

Verfügbarkeit prüfen

Women, thrombosis, and cancer: A gender-specific analysis

Thrombosis research, 2017-03, Vol.151, p.S21-S29

2017

Link zum Volltext

Verfügbarkeit prüfen

8-LB: Risk Profile of Comorbid Diabetes and Benefit of Rivaroxaban in Patients with Critical Limb Ischemia: Insights from VOYAGER PAD

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(68)
Humans
(65)
Cardiovascular System & Cardiology
(44)
Female
(39)
Peripheral Vascular Disease
(34)
Hematology
(29)
Male
(29)
Aged
(25)
Middle Aged
(24)
Risk Factors
(19)
Anticoagulants
(16)
Anticoagulants - Therapeutic Use
(16)
Hemorrhage - Chemically Induced
(16)
Venous Thromboembolism
(15)
Anticoagulants - Administration & Dosage
(14)
Anticoagulants - Adverse Effects
(14)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Rivaroxaban
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Rivaroxaban in Peripheral Artery Disease after Revascularization

Fondaparinux Sodium: Recent Advances in the Management of Thrombosis

Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs

Superficial Vein Thrombosis

Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women

Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD

Clinical presentation of deep vein thrombosis and pulmonary embolism

Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD

Treatment of venous thromboembolism during pregnancy

Use of anticoagulants in elderly patients

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

LMWH in cancer patients with renal impairment – better than warfarin?

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

Managing venous thromboembolism with novel oral anticoagulants in the elderly and other high-risk patient groups

Guidelines for the management of cancer and thrombosis – Special aspects in women

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD

Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD

Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD

Women, thrombosis, and cancer: A gender-specific analysis

8-LB: Risk Profile of Comorbid Diabetes and Benefit of Rivaroxaban in Patients with Critical Limb Ischemia: Insights from VOYAGER PAD

Suchergebnisse filtern